Literature DB >> 15530273

Red cell immunization in beta thalassaemia major.

Farhat Abbas Bhatti1, Nuzhat Salamat, Ali Nadeem, Naveeda Shabbir.   

Abstract

OBJECTIVE: To find out the frequency, pattern and factors influencing red cell immunization secondary to multiple blood transfusions in patients of beta-thalassaemia major.
DESIGN: A cross-sectional study. PLACE AND DURATION OF STUDY: Armed Forces Institute of Transfusion, Rawalpindi, in November 2002. PATIENTS AND METHODS: One hundred and sixty-one patients suffering from beta-thalassaemia major and on regular blood transfusions were included in the study. Their blood samples were tested for blood grouping, direct antiglobulin test and antibody screening/identification using reagents of DiaMed-ID Gel microtyping system.
RESULTS: The total rate of red cell immunization was found to be 6.84%. Red cell alloantibodies were detected in 4.97% patients, and belonged mainly to Rh system, with one example each of anti-K, anti-Jsb and anti-Jka. Direct antiglobulin test was positive in 3 patients (1.87%) with increased hemolysis. Two had warm panreactive IgG antibodies suggesting red cell autoimmunization. Red cells of the 3rd patient showed sensitization with c-3d, with presence of an autoreactive cold agglutinin in the serum having a titre of 1:4. The red cell alloantibody formation was not influenced by age at first transfusion, number of blood transfusions and ethnicity.
CONCLUSION: The rate of red cell alloimmunization in beta-thalassaemia major is relatively low in our setup and may be related to red cell homogeneity between the donor and recipient population. Routine pre-transfusion matching of blood, other than ABO and Rh "D" antigens is not recommended because of low rate of red cell alloimmunization, and high costs associated with such testing. Hyperhaemolysis, due to acquired red cell autoantibodies was found to be an important complication. Patients who develop this complication should be tested for presence of underlying alloantibodies and considered for immunosuppressive treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530273     DOI: 11.2004/JCPSP.657660

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  15 in total

1.  Prevalence of alloimmunisation in patients with beta thalassaemia major.

Authors:  Mehrnoush Kosaryan; Mohammad Reza Mahdavi; Payam Roshan; Mohammad Taher Hojjati
Journal:  Blood Transfus       Date:  2012-02-22       Impact factor: 3.443

2.  Detection and identification of red cell alloantibodies in multiply transfused thalassemia major patients: a prospective study.

Authors:  Roopam Jain; N Choudhury; U Chudgar; V Harimoorthy; P Desai; Jim Perkins; Susan T Johnson
Journal:  Indian J Hematol Blood Transfus       Date:  2013-06-19       Impact factor: 0.900

3.  Red blood cell antibodies in thalassemia patients in northern India: risk factors and literature review.

Authors:  Priti Elhence; Archana Solanki; Anupam Verma
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-22       Impact factor: 0.900

4.  Alloimmunization among transfusion-dependent thalassemia patients.

Authors:  Mohammad Hadi Sadeghian; Mohammad Reza Keramati; Zahra Badiei; Mehrangiz Ravarian; Hossein Ayatollahi; Houshang Rafatpanah; Mohammad Khajeh Daluei
Journal:  Asian J Transfus Sci       Date:  2009-07

5.  Red Cell Alloantibodies in Multiple Transfused Thalassaemia Patients.

Authors:  C N Chaudhari
Journal:  Med J Armed Forces India       Date:  2011-07-21

6.  Red cell alloimmunization in multitransfused patients and multiparous women.

Authors:  Jalada Patel; Rinku Shukla; Snehalata Gupte
Journal:  Indian J Hematol Blood Transfus       Date:  2009-07-05       Impact factor: 0.900

7.  Prevalence and specificities of red cell alloantibodies in transfusion-dependent beta thalassemia patients in Yazd.

Authors:  M Vaziri; H JavadzadehShahshahani; M Moghaddam; N Taghvaee
Journal:  Iran J Ped Hematol Oncol       Date:  2015-04-20

8.  High School Knowledge and Attitudes towards Thalassemia in Southeastern Iran.

Authors:  Ebrahim Miri-Moghaddam; Eisa Motaharitabar; Leila Erfannia; Alireza Dashipour; Marziyeh Houshvar
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2014

9.  Beta thalassemia major in a developing country: epidemiological, clinical and evolutionary aspects.

Authors:  Mohamed Bejaoui; Naouel Guirat
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-01-02       Impact factor: 2.576

10.  Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients.

Authors:  Hari Krishan Dhawan; Vijay Kumawat; Neelam Marwaha; Ratti Ram Sharma; Suchet Sachdev; Deepak Bansal; Ram Kumar Marwaha; Satyam Arora
Journal:  Asian J Transfus Sci       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.